We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
+9.37%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+648.16%
AUM
$24.3B
AUM Growth
+$757M
Cap. Flow
-$1.04B
Cap. Flow %
-4.28%
Top 10 Hldgs %
26.42%
Holding
1,541
New
37
Increased
296
Reduced
731
Closed
60

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$74.9M
2
VZ icon
Verizon
VZ
+$67.6M
3
TMUS icon
T-Mobile US
TMUS
+$55.1M
4
AFL icon
Aflac
AFL
+$49.5M
5
MRSH
Marsh
MRSH
+$47M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$392M
2
NVDA icon
NVIDIA
NVDA
+$164M
3
MSFT icon
Microsoft
MSFT
+$93.5M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$72.3M
5
IBM icon
IBM
IBM
+$61.8M

Sector Composition

Rank Sector Weight
1 Technology 30.54%
2 Healthcare 18.94%
3 Financials 12.78%
4 Consumer Discretionary 10.22%
5 Communication Services 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGA icon
1126
Reinsurance Group of America
RGA
$15.5B
$99K ﹤0.01%
711
VSXY
1127
Victoria's Secret
VSXY
$7.14B
$99K ﹤0.01%
+5,684
New +$143K
CHEF icon
1128
Chefs' Warehouse
CHEF
$4.43B
$98K ﹤0.01%
2,731
-237
-8% -$7.85K
TRMK icon
1129
Trustmark
TRMK
$2.83B
$98K ﹤0.01%
4,627
-675
-13% -$15.2K
ADEA icon
1130
Adeia
ADEA
$3.3B
$97K ﹤0.01%
8,766
ARI
1131
Apollo Commercial Real Estate
ARI
$872M
$97K ﹤0.01%
8,611
-2,401
-22% -$24.2K
EMBC icon
1132
Embecta
EMBC
$212M
$97K ﹤0.01%
4,512
-513
-10% -$14K
MD icon
1133
Pediatrix Medical
MD
$2.13B
$97K ﹤0.01%
6,826
UVV icon
1134
Universal Corp
UVV
$1.3B
$97K ﹤0.01%
1,933
-296
-13% -$15.6K
WLY icon
1135
John Wiley & Sons Class A
WLY
$2.76B
$96K ﹤0.01%
2,824
+2,157
+323% +$78.6K
IBTX
1136
DELISTED
Independent Bank Group, Inc.
IBTX
$96K ﹤0.01%
2,780
LMAT icon
1137
LeMaitre Vascular
LMAT
$1.81B
$95K ﹤0.01%
1,415
-223
-14% -$13.6K
ASTH icon
1138
Astrana Health
ASTH
$1.78B
$95K ﹤0.01%
2,999
-400
-12% -$13.7K
CWK icon
1139
Cushman & Wakefield Ltd
CWK
$3.29B
$94K ﹤0.01%
11,479
-1,709
-13% -$14.9K
UNFI icon
1140
United Natural Foods
UNFI
$2.91B
$94K ﹤0.01%
4,829
SAFT icon
1141
Safety Insurance
SAFT
$1.52B
$93K ﹤0.01%
1,291
SCHL icon
1142
Scholastic
SCHL
$801M
$93K ﹤0.01%
2,398
-171
-7% -$6.64K
SLVM icon
1143
Sylvamo
SLVM
$1.54B
$93K ﹤0.01%
2,287
-352
-13% -$15.2K
UFPT icon
1144
UFP Technologies
UFPT
$2.49B
$93K ﹤0.01%
+481
New +$74.5K
WWW icon
1145
Wolverine World Wide
WWW
$1.6B
$93K ﹤0.01%
6,317
AVNS
1146
DELISTED
Avanos Medical
AVNS
$92K ﹤0.01%
3,594
GNL icon
1147
Global Net Lease
GNL
$1.82B
$92K ﹤0.01%
8,904
WKC icon
1148
World Kinect Corp
WKC
$1.97B
$92K ﹤0.01%
4,468
-9,470
-68% -$226K
CRNC icon
1149
Cerence
CRNC
$417M
$91K ﹤0.01%
3,128
-254
-8% -$6.96K
DFIN icon
1150
Donnelley Financial Solutions
DFIN
$1.22B
$91K ﹤0.01%
1,988

Similar funds

KBC Group's Q2 2023 Portfolio in Review

As of Q2 2023, KBC Group held 1,541 positions worth $24.3B, up 3.2% from $23.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

KBC Group withdrew a net $1.04B in Q2 2023, closing 60 positions and reducing 731 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $49.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.

Against the trend, KBC Group opened a new position in Graco worth $12M.

  • KBC Group's largest Q2 2023 buy was Graco: 139,329 shares worth $12M.
  • KBC Group added most to Johnson & Johnson in Q2 2023, an estimated $74.9M increase.
  • KBC Group's biggest Q2 2023 reduction was Apple, cutting an estimated $392M.
  • KBC Group fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $49.2M.
  • KBC Group's ten largest holdings make up 26% of its $24.3B portfolio in Q2 2023.
  • KBC Group opened 37 new positions and closed 60 in Q2 2023.
  • KBC Group's portfolio value rose 3.2% quarter-over-quarter to $24.3B.

Based on KBC Group's 13F filing for Q2 2023, filed 28 Jul 2023.